KRISTIN ROCCO: Open Payments
NPI 1972162071 · ROSLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,427 in 48 payments from 10 companies in 2025. Trend: 2023 $2,405 · 2024 $3,239 · 2025 $1,427
Food & beverage: $1,427
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 9 | $664 |
| Actelion Pharmaceuticals US, Inc. | 10 | $172 |
| Alnylam Pharmaceuticals Inc. | 10 | $149 |
| AstraZeneca Pharmaceuticals LP | 6 | $121 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $71 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $71 |
| SCPHARMACEUTICALS INC. | 2 | $59 |
| ABIOMED | 2 | $49 |
| United Therapeutics Corporation | 2 | $47 |
| Novo Nordisk Inc | 1 | $24 |
Products named: THORATEC HEARTMATE 3 LVAS IMPLANT KIT, UPTRAVI, AMVUTTRA, CARDIOMEMS, FARXIGA, Kerendia, JARDIANCE, FUROSCIX.
Industry payments across NY — which companies pay providers there.
